IgG4-related Disease: a diagnostic challenge
Rodrigo Díaz Olmos; Marcelo Arlindo Vasconcelos Miranda Rodrigues; Cristiane Rúbia Ferreira; Rita de Cássia Franco Etrusco; Carla Romagnolli
Abstract
Keywords
References
1 Stone JH, Zen Y, Deshpande V. IgG4-Related Disease. N Engl J Med. 2012;366(6):539-51.
2 Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181-92.
3 Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4- related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1-14.
4 Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104(3):444-55.
5 Yamada K, Yamamoto M, Saeki T, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19(1):262.
6 Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine. 2015;94(15):e680.
7 Chen Y, Zhao JZ, Feng RE, et al. Types of organ involvement in patients with immunoglobulin G4- related disease. Chin Med J. 2016;129(13):1525-32.
8 Sekiguchi H, Horie R, Kanai M, Suzuki R, Yi ES, Ryu JH. IgG4- related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 2016;68(9):2290-9.
9 Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466-75.
10 Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology. 2015;54(11):1982-90.
11 Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812-9.
12 Fernández-Codina A, Martínez-Valle F, Pinilla B, et al. IgG4- related disease: results from a multicenter Spanish Registry. Medicine. 2015;94(32):e1275.
13 Mizushima I, Inoue D, Kawano M. Retroperitoneal fibrosis/periaortitis and hydronephrosis. In: Saito T, Stone JH, Nakashima H, Saeki T, Kawano M, editors. IgG4-related kidney disease. Tokyo: Springer; 2016. p. 159-71.
14 Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: an update. Mod Rheumatol. 2019;29(2):231-9.
15 Engelhart S, Glynn RJ, Schur PH. Disease associations with isolated elevation of each of the four IgG subclasses. Semin Arthritis Rheum. 2017;47(2):276-80.
16 Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4- related disease. Allergy. 2014;69(2):269-72.
17 Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol. 2012;22(1):21-30.
18 Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4- related disease. Annu Rev Pathol. 2014;9(1):315-47.
19 Guma M, Firestein GS. IgG4-related diseases. Best Pract Res Clin Rheumatol. 2012;26(4):425-38.
20 Perugino CA, Stone JH. Treatment of IgG4-related disease: current and future approaches. Z Rheumatol. 2016;75(7):681-6.
21 Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-14.
22 Zhang W, Stone JH. Management of IgG4-related disease. Lancet Rheum. 2019;1(1):E55-65.
23 Khosroshahi A, Wallace ZA, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688-99.
24 Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607-15.
Submitted date:
05/19/2021
Accepted date:
06/25/2021
Publication date:
08/20/2021